Innate Pharma S.A. (IPHA) Financial Ratios & Valuation Metrics Analysis - P/E, ROE, Debt Ratios & Profitability - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Innate Pharma S.A.

    NASDAQ: IPHA · Real-Time Price · USD
    2.02
    0.01 (0.50%)
    At close: Oct 03, 2025, 3:58 PM
    2.03
    0.50%
    After-hours: Oct 03, 2025, 04:00 PM EDT

    Innate Pharma S.A. Ratios and Metrics

    Financials in EUR. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    PE Ratio
    		 -2.91 -28.15 -4.77 -6.04
    PEG Ratio
    		 -0.01 0.32 -0.17 -0.00
    PS Ratio
    		 11.41 4.11 4.81 26.34
    PB Ratio
    		 16.30 4.11 5.12 2.97
    P/FCF Ratio
    		 -19.76 -6.1 -13.67 -5.34
    P/OCF Ratio
    		 -20.88 -6.54 -14.48 -5.46
    OCF/S Ratio
    		 -0.55 -0.63 -0.33 -4.83
    Debt / Equity Ratio
    		 3.51 0.77 0.78 0.41
    Quick Ratio
    		 2.60 3.73 3.38 1.73
    Current Ratio
    		 2.60 3.73 3.38 1.73
    Asset Turnover
    		 0.11 0.30 0.28 0.05
    Interest Coverage
    		 -91.12 -19.8 -199.39 -153.29
    Return on Equity
    		 -5.6 -0.15 -1.07 -0.49
    Return on Assets
    		 -0.45 -0.04 -0.28 -0.2
    Return on Invested Capital
    		 -0.59 -0.09 -0.34 -0.22
    Dividend Yield
    		 n/a n/a n/a n/a
    Payout Ratio
    		 n/a n/a n/a n/a
    Gross Profit Margin
    		 1.00 0.11 0.10 -1.84
    Net Profit Margin
    		 -3.92 -0.15 -1.01 -4.36
    Pretax Profit Margin
    		 -3.92 -0.15 -1.01 -3.75
    Operating Profit Margin
    		 -4.09 -0.24 -1 -3.95
    FCF Margin
    		 -0.58 -0.67 -0.35 -4.94
    EBITDA Margin
    		 -3.72 -0.04 -0.21 -3.57

    Add to Watchlist